Detalhe da pesquisa
1.
Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies.
Clin Exp Nephrol
; 28(5): 391-403, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530490
2.
Combined effect of canagliflozin and exercise training on high-fat diet-fed mice.
Am J Physiol Endocrinol Metab
; 318(4): E492-E503, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32017594
3.
Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Biochem Biophys Res Commun
; 492(2): 161-165, 2017 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28803984
4.
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study.
Diabetes Ther
; 15(5): 1187-1199, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554220
5.
Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan.
Adv Ther
; 39(4): 1642-1658, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138572
6.
Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance.
Adv Ther
; 39(1): 674-691, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853985
7.
Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan.
Adv Ther
; 37(5): 2477-2492, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32323194
8.
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan.
Adv Ther
; 37(3): 1065-1086, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31873865
9.
Safety and efficacy of canagliflozin in elderly patients with type 2 diabetes mellitus: a 1-year post-marketing surveillance in Japan.
Curr Med Res Opin
; 34(2): 319-327, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025285
10.
Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.
Diabetes Ther
; 9(2): 623-636, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435909
11.
Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus.
Expert Opin Pharmacother
; 19(2): 83-91, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268035
12.
Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.
J Gastroenterol
; 53(1): 140-151, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28669071
13.
Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients.
Adv Ther
; 35(6): 817-831, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777520
14.
Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.
Diabetes Ther
; 9(3): 1083-1097, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637459
15.
RNAi-mediated knockdown of mouse melanocortin-4 receptor in vitro and in vivo, using an siRNA expression construct based on the mir-187 precursor.
Exp Anim
; 66(1): 41-50, 2017 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27725374
16.
Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.
PLoS One
; 10(12): e0145849, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26720709